All Curated Mutation Sites in JEV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in JEV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
C
  
E
  
NS1
  
NS2A
  
NS2B
  
NS3
  
NS4B
  
NS5
  
prM
  

Keyword: NS2B
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 29593046 G12A
NS2B
NS2B
Cell line
R
T
View
2 29593046 G37A
NS2B
NS2B
Cell line
R
T
View
3 29593046 G47A
NS2B
NS2B
Cell line
R
T
View
4 29593046 P112A
NS2B
NS2B
Cell line
R
T
View
5 39684391 D55E
NS2B
NS2B
Cell line
G
R
View
6 39684391 E65D
NS2B
NS2B
Cell line
G
R
View
7 31381617 D81E
NS2B
NS2B
Cell line
G
View
8 31381617 L99V
NS2B
NS2B
Cell line
G
View
9 31381617 E55D
NS2B
NS2B
Cell line
G
View
10 31381617 D65E
NS2B
NS2B
Cell line
G
View
11 31381617 V99L
NS2B
NS2B
Cell line
G
View
12 31381617 K78N
NS2B
NS2B
Cell line
G
View
13 39775684 D65G
NS2B
NS2B
Cell line
R
View
14 39775684 E63D
NS2B
NS2B
Cell line
R
View
15 24362961 T102M
NS2B
NS2B
Cell line
JEV Infection
R
L
View
16 27053551 L38A
NS2B
NS2B
Encephalitis, Japanese
View
17 27053551 R101A
NS2B
NS2B
Encephalitis, Japanese
View
18 27053551 G12L
NS2B
NS2B
Encephalitis, Japanese
View
19 27053551 G37L
NS2B
NS2B
Encephalitis, Japanese
View
20 27053551 P112A
NS2B
NS2B
Encephalitis, Japanese
View
21 17467838 S46I
NS2B
NS2B

View
Contents
Description

The table shows all curated mutation sites of JEV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.